U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Sodium Chloride Injection, 0.9% Vials and Syringes
Status: Currently in Shortage
»Date first posted: 06/21/2018
»Therapeutic Categories: Other

Expand all

Fresenius Kabi USA, LLC (Reverified 03/31/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02) Available Check wholesalers for inventory Increase in Demand
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10) Available Check wholesalers for inventory Demand increase
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20) Available Check wholesalers for inventory Demand increase
Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00) Backordered. Next release date not available at this time. Increase in Demand

Guerbet LLC (Revised 10/03/2022)

Company Contact Information:
877-729-6679

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
125 mL PFS (NDC 0019-1188-81) On backorder. Next batch will be available in April 2022, and the current demand can be fulfilled by May 2022. Other
125 mL PFS RFID Tag (NDC 0019-1188-27) Available; Next batch will be available May 2022. Other

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 10/03/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.9%, 2 mL vial (NDC 0641-0497-25) This presentation is temporarily on backorder. Recovery is TBD at this time. Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 03/31/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10) Available Other
10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12) Available Other
0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20) Available Other
0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50) Available Other

Medefil, Inc. (Revised 10/03/2022)

Company Contact Information:
630-682-4600

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30) Available Available

Spectra Medical Devices, Inc. (Revised 10/03/2022)

Company Contact Information:
978-657-0889

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.9% 10mL Ampule (NDC 65282-1510-1) Currently available, in stock, Production is ongoing Other
0.9% 5mL Ampule (NDC 65282-1505-1) Currently available, in stock, Production is ongoing Other
Back to Top